Skip to content

Effect of Praneem polyherbal formulations against Infection of HPV in Uterine cervix.

â??Study on the efficacy of Praneem Cream, Praneem Polyherbal tablets on HPV infection of the Cervix-uteri: A Pilot study.â??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2008/091/000043
Enrollment
20
Registered
2008-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Praneem polyherbal tablet: Study Intervention is Praneem polyherbal tablet 500mg (Purified extracts of Neem Leaves 80mg
Purified saponins from sapindus muckerossi 40mg
Mentha citrate oil 20mg
Quinine Hydrochloride 30mg
dispensed in pharmacopially approved expicients) for 30 days excluding menstrual cycle. Control Intervention1: â??Placeboâ?? (no active ingredients):

Sponsors

Indian Council of Medical Research, Ansari Nagar, New Delhi- 110 029
Lead Sponsor
Institute of Cytology &amp
Collaborator
Preventive Oncology (ICMR), I-7, Sector 39, NOIDA, India &amp
Collaborator
Talwar Research Foundation, New Delhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult females in reproductive age group of 30 years or more with HPV infection or inflammatory lesions.

Exclusion criteria

Exclusion criteria: 1) Pregnant Women 2) Patient with menstrual irregularities and any tumor or other concomitant therapies.

Design outcomes

Primary

MeasureTime frame
Disappearance of reduction of HPV DNA Disappearance of lesions on visual inspection, Disappearance of lesions on colposcopic examination.Timepoint: Time-points: 30 days

Secondary

MeasureTime frame
Disappearance of lesions on cytology. Disappearance of lesions on colposcopic examination. Time-points: 30 daysTimepoint: Time-points: 30 days

Countries

India

Contacts

Public ContactDr. Bhudev C. Das

Director

bcdas48@hotmail.com91-120-2579471/72

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026